MEDOVEX CORP Inactive Instrument
Medovex Corp Share Price OTC Bulletin Board
Equities
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Sales 2021 | 1.61M 124M | Sales 2022 | 453K 34.97M | Capitalization | 1.62M 125M |
|---|---|---|---|---|---|
| Net income 2021 | -4M -308M | Net income 2022 | -10M -771M | EV / Sales 2021 | 7.95 x |
| Net Debt 2021 | 3.52M 272M | Net Debt 2022 | 3.92M 303M | EV / Sales 2022 | 12.2 x |
| P/E ratio 2021 |
-1.73
x | P/E ratio 2022 |
-0.08
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 35.62% |
More Fundamentals
* Assessed data
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 07/01/19 | |
Jeremy Daniel
DFI | Director of Finance/CFO | 48 | 03/02/19 |
Tanya Rhodes
CTO | Chief Tech/Sci/R&D Officer | 64 | 14/06/20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 16/01/22 | |
| Chief Executive Officer | 53 | 07/01/19 | |
| Chairman | 77 | 07/01/19 |
Innoveren Scientific Inc. is a life science and biotech incubator company. The Company is focused on advancing new technologies in areas of unmet need across multiple indications for improving patient lives. The Company is also focused on investing in and fosters technologies that are supported by a scientific foundation.
| 1st Jan change | Capi. | |
|---|---|---|
| +4.51% | 208B | |
| +8.83% | 182B | |
| +29.80% | 155B | |
| +35.28% | 115B | |
| +2.55% | 66.52B | |
| +14.87% | 53.93B | |
| -6.47% | 46.26B | |
| -2.49% | 38.22B | |
| +6.98% | 36.6B |
